Nina Kjellson brings a Nordic perspective to biotech investing, focusing on therapeutics for serious, underserved conditions like addiction and neurological diseases before impact investing became mainstream. She created the WoVen podcast platform to highlight senior women across healthcare and tech, while leading Canaan's Women of Venture program and serving as a recognized advocate for gender diversity in venture capital.

• Deep commitment to the life sciences and biotech sectors, particularly regarding cancer research and cell therapies. Frequently celebrates portfolio milestones, such as Tyra Biosciences developing next-generation treatments to overcome drug resistance or Carisma's work on macrophage cell therapy.
• Strong advocacy for diversity, equity, and inclusion within the startup and healthcare ecosystems. Actively promotes women-led venture funds and celebrates wins for female entrepreneurs, such as highlighting the success of a women-led firm closing a significant first fund.
• Focus on the intersection of healthcare policy and industry stability. Expresses a desire for more trusting discourse between lawmakers and the pharmaceutical industry, specifically noting how collaboration and personal sacrifice helped biotech startups survive banking challenges like the SVB crisis.
• Appreciation for the broader healthcare infrastructure and the scientists behind it. Highlights the critical role of healthcare workers during the pandemic and publicly thanks the scientific community, regulators, and trial participants for advancements like vaccines.
• Interest in the personal elements of leadership and family achievements. Shares pride in family members' creative projects, such as a stepson's cinematography work on a documentary about the slave ship Clotilda, suggesting an appreciation for the arts alongside science.